C29H39ClN7O2P
584.1 g/mol
APIDanger
Brigatinib
CAS1197953-54-0
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Brigatinib is a small-molecule compound used as an active pharmaceutical ingredient. It is designed to inhibit specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
Pharmaceutical raw material for targeted cancer therapy researchCompound for ALK-positive non-small cell lung cancer studiesCompound for ALK-positive anaplastic large cell lymphoma studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1197953-54-0
Related Compounds
SimilarStructure SimilarSimilarity 0.77
AP-26113
CAS1197958-12-5
pharmaceutical raw material
ReferenceSame Category
6-methylthioguanine
CAS1198-47-6
pharmaceutical raw material
ReferenceSame Category
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
CAS119812-29-2
pharmaceutical raw material
ReferenceSame Category
(S)-3-Aminoquinuclidine dihydrochloride
CAS119904-90-4
pharmaceutical raw material
ReferenceSame Category
Z944
CAS1199236-64-0
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
InChIKey
AILRADAXUVEEIR-UHFFFAOYSA-N
SMILES
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC
Synonyms (14)
- 6GY
- Brigatinib (JAN/USAN)
- Alunbrig (TN)
- Brigatinib
- Brigatinib (AP-26113)
- brigatinibum